Sponsors (4)
The bill invests federal resources to boost HPV vaccination, outreach, and screening—especially for underserved communities—improving long-term cancer prevention and public-health capacity, but it increases near-term federal spending, adds implementation burdens, and may have limited reach or sustainability without continued funding and strong local implementation.
Adolescents (especially ages 9–12) and their parents: the bill increases HPV vaccination uptake through provider recommendations, evidence-based education, culturally tailored outreach, and local grant-funded programs.
Women and patients at risk for HPV-related cancers: the bill expands and bettercoordinates screening (including self-collection) to increase early detection and improve health outcomes.
State, local, and Tribal public health departments and nonprofits: predictable multi-year mandatory funding and federal grants strengthen planning, program continuity, and local outreach capacity through 2030.
Taxpayers and the federal budget: the bill increases federal spending (about $300 million/year for screening programs — ~$1.5 billion FY2026–2030 — plus annual awareness campaign funding), which could affect deficits or require offsets.
Healthcare providers and program administrators: the initiative may increase burdens (counseling, reminder systems, outreach) and add administrative complexity; changes to coordination/oversight risk reducing stakeholder input and program effectiveness.
Rural, low-income, and minority communities: limited campaign funding (and modest program resources) could constrain reach and evaluation, so disparities may persist or improve only modestly without additional investment.
Based on analysis of 4 sections of legislative text.
Directs CDC to run a funded national HPV prevention campaign and adds multi-year funding for breast and cervical cancer screening (FY2026–2030).
Introduced December 10, 2025 by Kathy Castor · Last progress December 10, 2025
Directs the Centers for Disease Control and Prevention to run a national public-awareness campaign to increase HPV vaccination, correct misinformation, and promote HPV prevention and screening; requires consultation with experts and funds grant awards to nonprofits and state, local, and Tribal health departments. It also provides new multi-year funding to expand the Breast and Cervical Cancer Early Detection Program and requires a progress report to Congress on the campaign's activities and impact.